Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg

Business

FILE PHOTO: Exact Sciences Laboratories building is shown in Madison, Wisconsin, U.S., March 28, 2019. REUTERS/Howard Schneider

(Reuters) – Cancer diagnostics company Exact Sciences Corp (EXAS.O) is in advanced negotiations to buy healthcare company Genomic Health Inc (GHDX.O) for about $2.8 billion to strengthen its cancer testing, Bloomberg reported on Saturday.

A deal could be announced as early as next week but the talks could still be delayed or fall apart altogether, according to the report, which cited people familiar with the matter.

Exact Sciences and Genomic Health did not respond immediately to a Reuters request for comment on Saturday.

Reporting by Kanishka Singh in Bengaluru; Editing by Sonya Hepinstall

Products You May Like

Articles You May Like

Writing a woman on the verge
War Of The Worlds moment for NASA after ‘disturbing’ audio clip shared accidentally
Sunak says voting for Reform would hand Labour ‘blank cheque’
Rewire
Joe Alwyn Hints at Timeline of Taylor Swift Breakup